Published in Mol Microbiol on June 01, 2007
Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol (2012) 3.52
Analysis of the RpoS regulon in Borrelia burgdorferi in response to mammalian host signals provides insight into RpoS function during the enzootic cycle. Mol Microbiol (2007) 2.32
A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi. Infect Immun (2008) 2.15
Both decorin-binding proteins A and B are critical for the overall virulence of Borrelia burgdorferi. Infect Immun (2008) 1.67
In vivo expression technology identifies a novel virulence factor critical for Borrelia burgdorferi persistence in mice. PLoS Pathog (2013) 1.49
BosR (BB0647) governs virulence expression in Borrelia burgdorferi. Mol Microbiol (2009) 1.42
Biology of infection with Borrelia burgdorferi. Infect Dis Clin North Am (2008) 1.35
Genetic basis for retention of a critical virulence plasmid of Borrelia burgdorferi. Mol Microbiol (2007) 1.29
Genome stability of Lyme disease spirochetes: comparative genomics of Borrelia burgdorferi plasmids. PLoS One (2012) 1.28
A chromosomally encoded virulence factor protects the Lyme disease pathogen against host-adaptive immunity. PLoS Pathog (2009) 1.24
Analysis of the HD-GYP domain cyclic dimeric GMP phosphodiesterase reveals a role in motility and the enzootic life cycle of Borrelia burgdorferi. Infect Immun (2011) 1.21
GuaA and GuaB are essential for Borrelia burgdorferi survival in the tick-mouse infection cycle. J Bacteriol (2009) 1.20
Analysis of an ordered, comprehensive STM mutant library in infectious Borrelia burgdorferi: insights into the genes required for mouse infectivity. PLoS One (2012) 1.19
BB0323 function is essential for Borrelia burgdorferi virulence and persistence through tick-rodent transmission cycle. J Infect Dis (2009) 1.18
Analysis of a Borrelia burgdorferi phosphodiesterase demonstrates a role for cyclic-di-guanosine monophosphate in motility and virulence. Mol Microbiol (2010) 1.16
Borrelia burgdorferi and tick proteins supporting pathogen persistence in the vector. Future Microbiol (2013) 1.12
A tightly regulated surface protein of Borrelia burgdorferi is not essential to the mouse-tick infectious cycle. Infect Immun (2008) 1.10
Defining the plasmid-borne restriction-modification systems of the Lyme disease spirochete Borrelia burgdorferi. J Bacteriol (2010) 1.06
Experimental infections of the reservoir species Peromyscus leucopus with diverse strains of Borrelia burgdorferi, a Lyme disease agent. MBio (2012) 1.04
Analysis of the Borrelia burgdorferi cyclic-di-GMP-binding protein PlzA reveals a role in motility and virulence. Infect Immun (2011) 1.03
Role of the surface lipoprotein BBA07 in the enzootic cycle of Borrelia burgdorferi. Infect Immun (2010) 1.03
Motility is crucial for the infectious life cycle of Borrelia burgdorferi. Infect Immun (2013) 1.01
Characterization of unique regions of Borrelia burgdorferi surface-located membrane protein 1. Infect Immun (2010) 1.00
OspC-independent infection and dissemination by host-adapted Borrelia burgdorferi. Infect Immun (2009) 1.00
Characterization and in vitro reaction properties of 19 unique hairpin telomeres from the linear plasmids of the lyme disease spirochete. J Biol Chem (2009) 1.00
In vitro CpG methylation increases the transformation efficiency of Borrelia burgdorferi strains harboring the endogenous linear plasmid lp56. J Bacteriol (2008) 1.00
Borrelia chilensis, a new member of the Borrelia burgdorferi sensu lato complex that extends the range of this genospecies in the Southern Hemisphere. Environ Microbiol (2013) 0.98
Lipoprotein succession in Borrelia burgdorferi: similar but distinct roles for OspC and VlsE at different stages of mammalian infection. Mol Microbiol (2013) 0.95
Multiple and Diverse vsp and vlp Sequences in Borrelia miyamotoi, a Hard Tick-Borne Zoonotic Pathogen. PLoS One (2016) 0.94
Use of the Cre-lox recombination system to investigate the lp54 gene requirement in the infectious cycle of Borrelia burgdorferi. Infect Immun (2010) 0.93
High-throughput plasmid content analysis of Borrelia burgdorferi B31 by using Luminex multiplex technology. Appl Environ Microbiol (2010) 0.92
Inactivation of genes for antigenic variation in the relapsing fever spirochete Borrelia hermsii reduces infectivity in mice and transmission by ticks. PLoS Pathog (2014) 0.91
Effect of Borrelia burgdorferi OspC at the site of inoculation in mouse skin. Infect Immun (2010) 0.89
Transposon mutagenesis as an approach to improved understanding of Borrelia pathogenesis and biology. Front Cell Infect Microbiol (2014) 0.89
Population bottlenecks during the infectious cycle of the Lyme disease spirochete Borrelia burgdorferi. PLoS One (2014) 0.88
Borrelia burgdorferi bb0426 encodes a 2'-deoxyribosyltransferase that plays a central role in purine salvage. Mol Microbiol (2009) 0.88
Borrelia burgdorferi linear plasmid 38 is dispensable for completion of the mouse-tick infectious cycle. Infect Immun (2011) 0.87
Enhanced detection of host response antibodies to Borrelia burgdorferi using immuno-PCR. Clin Vaccine Immunol (2013) 0.87
BBK07, a dominant in vivo antigen of Borrelia burgdorferi, is a potential marker for serodiagnosis of Lyme disease. Clin Vaccine Immunol (2009) 0.86
Regulation of the virulence determinant OspC by bbd18 on linear plasmid lp17 of Borrelia burgdorferi. J Bacteriol (2011) 0.85
Molecular characterization of the Borrelia burgdorferi in vivo-essential protein PncA. Microbiology (2011) 0.85
Interaction of Borrelia burgdorferi Hbb with the p66 promoter. Nucleic Acids Res (2009) 0.85
Borrelia burgdorferi harbors a transport system essential for purine salvage and mammalian infection. Infect Immun (2012) 0.84
Purification and properties of the plasmid maintenance proteins from the Borrelia burgdorferi linear plasmid lp17. J Bacteriol (2008) 0.82
CsrA (BB0184) is not involved in activation of the RpoN-RpoS regulatory pathway in Borrelia burgdorferi. Infect Immun (2014) 0.81
Complete genome sequence of Borrelia afzelii K78 and comparative genome analysis. PLoS One (2015) 0.81
Detection and quantification of Lyme spirochetes using sensitive and specific molecular beacon probes. BMC Microbiol (2009) 0.81
Altered murine tissue colonization by Borrelia burgdorferi following targeted deletion of linear plasmid 17-carried genes. Infect Immun (2012) 0.80
Induction of type I and type III interferons by Borrelia burgdorferi correlates with pathogenesis and requires linear plasmid 36. PLoS One (2014) 0.80
Spent culture medium from virulent Borrelia burgdorferi increases permeability of individually perfused microvessels of rat mesentery. PLoS One (2008) 0.80
Requirements for Borrelia burgdorferi plasmid maintenance. Plasmid (2012) 0.80
Detection of established virulence genes and plasmids to differentiate Borrelia burgdorferi strains. Infect Immun (2012) 0.79
Comparative molecular analyses of Borrelia burgdorferi sensu stricto strains B31 and N40D10/E9 and determination of their pathogenicity. BMC Microbiol (2012) 0.79
Borrelia burgdorferi CheD Promotes Various Functions in Chemotaxis and the Pathogenic Life Cycle of the Spirochete. Infect Immun (2016) 0.78
BB0238, a presumed tetratricopeptide repeat-containing protein, is required during Borrelia burgdorferi mammalian infection. Infect Immun (2014) 0.77
How do lyme borrelia organisms cause disease? The quest for virulence determinants(). Open Neurol J (2012) 0.77
Borrelia burgdorferi linear plasmid 28-3 confers a selective advantage in an experimental mouse-tick infection model. Infect Immun (2013) 0.77
Gene bb0318 is critical for the oxidative stress response and infectivity of Borrelia burgdorferi. Infect Immun (2016) 0.77
In vivo expression technology and 5' end mapping of the Borrelia burgdorferi transcriptome identify novel RNAs expressed during mammalian infection. Nucleic Acids Res (2016) 0.76
Function of the Borrelia burgdorferi FtsH Homolog Is Essential for Viability both In Vitro and In Vivo and Independent of HflK/C. MBio (2016) 0.76
Molecular dissection of a Borrelia burgdorferi in vivo essential purine transport system. Infect Immun (2015) 0.76
Use of an endogenous plasmid locus for stable in trans complementation in Borrelia burgdorferi. Appl Environ Microbiol (2014) 0.75
Borrelia burgdorferi CheY2 is dispensable for chemotaxis or motility but crucial for the infectious life cycle of the spirochete. Infect Immun (2016) 0.75
Plasmid diversity and phylogenetic consistency in the Lyme disease agent Borrelia burgdorferi. BMC Genomics (2017) 0.75
Functional Equivalence of OspA and OspB, but Not OspC, in Tick Colonization by Borrelia burgdorferi. Infect Immun (2016) 0.75
A high-throughput genetic screen identifies previously uncharacterized Borrelia burgdorferi genes important for resistance against reactive oxygen and nitrogen species. PLoS Pathog (2017) 0.75
Induction of indoleamine 2,3-dioxygenase by Borrelia burgdorferi in human immune cells correlates with pathogenic potential. J Leukoc Biol (2014) 0.75
Lyme disease-a tick-borne spirochetosis? Science (1982) 27.50
The spirochetal etiology of Lyme disease. N Engl J Med (1983) 21.59
Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med (1985) 20.49
Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature (1997) 19.08
CDD: a Conserved Domain Database for protein classification. Nucleic Acids Res (2005) 18.85
HMDB: the Human Metabolome Database. Nucleic Acids Res (2007) 13.38
Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci U S A (1995) 9.93
A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol (2000) 7.60
Lyme disease. N Engl J Med (2001) 7.29
Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation. Infect Immun (1988) 6.64
Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell (1997) 6.36
New pUC-derived cloning vectors with different selectable markers and DNA replication origins. Gene (1991) 4.90
Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc Natl Acad Sci U S A (2000) 4.81
Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. J Clin Microbiol (2000) 4.71
Reservoir competence of white-footed mice for Lyme disease spirochetes. Am J Trop Med Hyg (1987) 4.13
DNA microarray analysis of differential gene expression in Borrelia burgdorferi, the Lyme disease spirochete. Proc Natl Acad Sci U S A (2002) 3.82
Lyme borreliosis: relation of its causative agent to its vectors and hosts in North America and Europe. Annu Rev Entomol (1991) 3.75
Clonal polymorphism of Borrelia burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain background. Infect Immun (2002) 3.65
Electrotransformation of the spirochete Borrelia burgdorferi. Methods Mol Biol (1995) 3.50
Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1. Infect Immun (2001) 3.31
Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc Natl Acad Sci U S A (2001) 3.28
Profiling of temperature-induced changes in Borrelia burgdorferi gene expression by using whole genome arrays. Infect Immun (2003) 3.19
A plasmid-encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host. Mol Microbiol (2003) 3.17
Dissemination and salivary delivery of Lyme disease spirochetes in vector ticks (Acari: Ixodidae). J Med Entomol (1987) 3.00
Isolation of a circular plasmid region sufficient for autonomous replication and transformation of infectious Borrelia burgdorferi. Mol Microbiol (2001) 2.95
Effects of environmental pH on membrane proteins in Borrelia burgdorferi. Infect Immun (1999) 2.91
Efficient targeted mutagenesis in Borrelia burgdorferi. J Bacteriol (2000) 2.89
The urinary bladder, a consistent source of Borrelia burgdorferi in experimentally infected white-footed mice (Peromyscus leucopus). J Clin Microbiol (1988) 2.85
The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature (2005) 2.82
Role of saliva in blood-feeding by arthropods. Annu Rev Entomol (1987) 2.78
Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg (1992) 2.71
Identification of a 47 kDa fibronectin-binding protein expressed by Borrelia burgdorferi isolate B31. Mol Microbiol (1998) 2.68
Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi. Infect Immun (1998) 2.56
Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection. Infect Immun (2006) 2.54
High- and low-infectivity phenotypes of clonal populations of in vitro-cultured Borrelia burgdorferi. Infect Immun (1995) 2.39
Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. J Clin Microbiol (1999) 2.39
Antibody to a 39-kilodalton Borrelia burgdorferi antigen (P39) as a marker for infection in experimentally and naturally inoculated animals. J Clin Microbiol (1991) 2.32
Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence. Infect Immun (2006) 2.24
The burgeoning molecular genetics of the Lyme disease spirochaete. Nat Rev Microbiol (2005) 2.11
BBE02 disruption mutants of Borrelia burgdorferi B31 have a highly transformable, infectious phenotype. Infect Immun (2004) 2.08
New antibiotic resistance cassettes suitable for genetic studies in Borrelia burgdorferi. J Mol Microbiol Biotechnol (2003) 2.07
The absence of linear plasmid 25 or 28-1 of Borrelia burgdorferi dramatically alters the kinetics of experimental infection via distinct mechanisms. Infect Immun (2003) 2.06
Correlation of plasmids with infectivity of Borrelia burgdorferi sensu stricto type strain B31. Infect Immun (1996) 2.01
Inactivation of the fibronectin-binding adhesin gene bbk32 significantly attenuates the infectivity potential of Borrelia burgdorferi. Mol Microbiol (2006) 1.93
Decreased electroporation efficiency in Borrelia burgdorferi containing linear plasmids lp25 and lp56: impact on transformation of infectious B. burgdorferi. Infect Immun (2002) 1.83
Identification of a candidate glycosaminoglycan-binding adhesin of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol (2000) 1.81
bptA (bbe16) is essential for the persistence of the Lyme disease spirochete, Borrelia burgdorferi, in its natural tick vector. Proc Natl Acad Sci U S A (2005) 1.66
Evidence of past recombination events among the genes encoding the Erp antigens of Borrelia burgdorferi. Microbiology (1998) 1.66
Experimental assessment of the roles of linear plasmids lp25 and lp28-1 of Borrelia burgdorferi throughout the infectious cycle. Infect Immun (2004) 1.55
Evidence that the variable regions of the central domain of VlsE are antigenic during infection with lyme disease spirochetes. Infect Immun (2002) 1.53
Borrelia burgdorferi lacking BBK32, a fibronectin-binding protein, retains full pathogenicity. Infect Immun (2006) 1.52
The essential nature of the ubiquitous 26-kilobase circular replicon of Borrelia burgdorferi. J Bacteriol (2004) 1.50
Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain. Infect Immun (2006) 1.50
Experimental infection of Ixodes scapularis larvae (Acari: Ixodidae) by immersion in low passage cultures of Borrelia burgdorferi. J Med Entomol (2003) 1.50
Characterization of cp18, a naturally truncated member of the cp32 family of Borrelia burgdorferi plasmids. J Bacteriol (1997) 1.48
Salp25D, an Ixodes scapularis antioxidant, is 1 of 14 immunodominant antigens in engorged tick salivary glands. J Infect Dis (2001) 1.45
Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferi. J Biol Chem (2001) 1.42
Analysis of mechanisms associated with loss of infectivity of clonal populations of Borrelia burgdorferi B31MI. Infect Immun (2001) 1.41
Plasmid stability during in vitro propagation of Borrelia burgdorferi assessed at a clonal level. Infect Immun (2003) 1.40
Saliva of the tick Ixodes dammini inhibits neutrophil function. Exp Parasitol (1990) 1.38
Comparative genome hybridization reveals substantial variation among clinical isolates of Borrelia burgdorferi sensu stricto with different pathogenic properties. J Bacteriol (2006) 1.34
Analysis of Borrelia burgdorferi vlsE gene expression and recombination in the tick vector. Infect Immun (2001) 1.32
Role of adenine deaminase in purine salvage and nitrogen metabolism and characterization of the ade gene in Bacillus subtilis. J Bacteriol (1996) 1.31
Association of linear plasmid 28-1 with an arthritic phenotype of Borrelia burgdorferi. Infect Immun (2005) 1.30
Mapping the ligand-binding region of Borrelia burgdorferi fibronectin-binding protein BBK32. Infect Immun (2001) 1.28
Effects of vlsE complementation on the infectivity of Borrelia burgdorferi lacking the linear plasmid lp28-1. Infect Immun (2004) 1.22
Intact purine biosynthesis pathways are required for wild-type virulence of Brucella abortus 2308 in the BALB/c mouse model. Infect Immun (2004) 1.20
Coinoculation of Borrelia spp. with tick salivary gland lysate enhances spirochete load in mice and is tick species-specific. J Parasitol (2002) 1.19
Infectious cycle analysis of a Borrelia burgdorferi mutant defective in transport of chitobiose, a tick cuticle component. Vector Borne Zoonotic Dis (2004) 1.16
Plasmid requirements for infection of ticks by Borrelia burgdorferi. Vector Borne Zoonotic Dis (2005) 1.15
A second allele of eppA in Borrelia burgdorferi strain B31 is located on the previously undetected circular plasmid cp9-2. J Bacteriol (2000) 1.13
Defining plasmids required by Borrelia burgdorferi for colonization of tick vector Ixodes scapularis (Acari: Ixodidae). J Med Entomol (2005) 1.12
Analysis of virulence and inflammatory potential of Shigella flexneri purine biosynthesis mutants. Infect Immun (2003) 1.11
Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology. Infect Immun (1995) 1.11
Tick saliva reduces adherence and area of human neutrophils. Infect Immun (2004) 1.10
Identification and quantitation of nucleosides, bases and other UV-absorbing compounds in serum, using reversed-phase high-performance liquid chromatography. II. Evaluation of human sera. J Chromatogr (1979) 1.06
Genetic variation at the vlsE locus of Borrelia burgdorferi within ticks and mice over the course of a single transmission cycle. J Bacteriol (2003) 1.06
Hematogenous dissemination in early Lyme disease. Wien Klin Wochenschr (2006) 1.01
Adenine deaminase activity of the yicP gene product of Escherichia coli. Biosci Biotechnol Biochem (2001) 0.94
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol (2012) 5.18
Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc Natl Acad Sci U S A (2004) 3.84
Clonal polymorphism of Borrelia burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain background. Infect Immun (2002) 3.65
Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection. Infect Immun (2006) 2.54
Borrelia burgdorferi sigma54 is required for mammalian infection and vector transmission but not for tick colonization. Proc Natl Acad Sci U S A (2005) 2.41
Monoclonal antibodies that target pathological assemblies of Abeta. J Neurochem (2006) 2.32
The burgeoning molecular genetics of the Lyme disease spirochaete. Nat Rev Microbiol (2005) 2.11
New antibiotic resistance cassettes suitable for genetic studies in Borrelia burgdorferi. J Mol Microbiol Biotechnol (2003) 2.07
Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol (2004) 1.81
Experimental assessment of the roles of linear plasmids lp25 and lp28-1 of Borrelia burgdorferi throughout the infectious cycle. Infect Immun (2004) 1.55
Delineating the requirement for the Borrelia burgdorferi virulence factor OspC in the mammalian host. Infect Immun (2006) 1.55
In vivo expression technology identifies a novel virulence factor critical for Borrelia burgdorferi persistence in mice. PLoS Pathog (2013) 1.49
Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging (2006) 1.43
Genome-wide transposon mutagenesis of Borrelia burgdorferi for identification of phenotypic mutants. Appl Environ Microbiol (2004) 1.42
Plasmid stability during in vitro propagation of Borrelia burgdorferi assessed at a clonal level. Infect Immun (2003) 1.40
Biology of infection with Borrelia burgdorferi. Infect Dis Clin North Am (2008) 1.35
Genetic basis for retention of a critical virulence plasmid of Borrelia burgdorferi. Mol Microbiol (2007) 1.29
Role of acetyl-phosphate in activation of the Rrp2-RpoN-RpoS pathway in Borrelia burgdorferi. PLoS Pathog (2010) 1.29
Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector. Infect Immun (2008) 1.21
GuaA and GuaB are essential for Borrelia burgdorferi survival in the tick-mouse infection cycle. J Bacteriol (2009) 1.20
The plasmids of Borrelia burgdorferi: essential genetic elements of a pathogen. Plasmid (2004) 1.18
Differential control of Yersinia pestis biofilm formation in vitro and in the flea vector by two c-di-GMP diguanylate cyclases. PLoS One (2011) 1.18
Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain. Neurobiol Dis (2002) 1.17
New pedigrees and novel mutation expand the phenotype of REEP1-associated hereditary spastic paraplegia (HSP). Neurogenetics (2008) 1.17
Infectious cycle analysis of a Borrelia burgdorferi mutant defective in transport of chitobiose, a tick cuticle component. Vector Borne Zoonotic Dis (2004) 1.16
Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998. Urology (2002) 1.15
Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DIABLO. J Am Coll Cardiol (2004) 1.12
Defining plasmids required by Borrelia burgdorferi for colonization of tick vector Ixodes scapularis (Acari: Ixodidae). J Med Entomol (2005) 1.12
A tightly regulated surface protein of Borrelia burgdorferi is not essential to the mouse-tick infectious cycle. Infect Immun (2008) 1.10
Clinical implications of apoptosis in ischemic myocardium. Curr Probl Cardiol (2006) 1.09
Identification of potential virulence determinants by Himar1 transposition of infectious Borrelia burgdorferi B31. Infect Immun (2006) 1.08
Purine salvage pathways among Borrelia species. Infect Immun (2007) 1.06
Defining the plasmid-borne restriction-modification systems of the Lyme disease spirochete Borrelia burgdorferi. J Bacteriol (2010) 1.06
PTEN depletion rescues axonal growth defect and improves survival in SMN-deficient motor neurons. Hum Mol Genet (2010) 1.06
Differential telomere processing by Borrelia telomere resolvases in vitro but not in vivo. J Bacteriol (2006) 1.04
Motility is crucial for the infectious life cycle of Borrelia burgdorferi. Infect Immun (2013) 1.01
OspC-independent infection and dissemination by host-adapted Borrelia burgdorferi. Infect Immun (2009) 1.00
Cross-species surface display of functional spirochetal lipoproteins by recombinant Borrelia burgdorferi. Infect Immun (2004) 0.99
The β₃-integrin ligand of Borrelia burgdorferi is critical for infection of mice but not ticks. Mol Microbiol (2012) 0.97
Lipoprotein succession in Borrelia burgdorferi: similar but distinct roles for OspC and VlsE at different stages of mammalian infection. Mol Microbiol (2013) 0.95
Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial. Amyotroph Lateral Scler Other Motor Neuron Disord (2004) 0.95
Competitive advantage of Borrelia burgdorferi with outer surface protein BBA03 during tick-mediated infection of the mammalian host. Infect Immun (2012) 0.95
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS. Amyotroph Lateral Scler (2012) 0.95
Transposon mutagenesis of the lyme disease agent Borrelia burgdorferi. Methods Mol Biol (2008) 0.94
Use of the Cre-lox recombination system to investigate the lp54 gene requirement in the infectious cycle of Borrelia burgdorferi. Infect Immun (2010) 0.93
Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.90
Beyond intuition: patient fever symptom experience. J Pain Symptom Manage (2013) 0.90
Characterization of the Bat proteins in the oxidative stress response of Leptospira biflexa. BMC Microbiol (2012) 0.90
The impact of fatigue and psychosocial variables on quality of life for patients with motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.89
Using the bioconductor GeneAnswers package to interpret gene lists. Methods Mol Biol (2012) 0.89
Borrelia burgdorferi bb0426 encodes a 2'-deoxyribosyltransferase that plays a central role in purine salvage. Mol Microbiol (2009) 0.88
The El Escorial criteria: strengths and weaknesses. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.88
Borrelia burgdorferi linear plasmid 38 is dispensable for completion of the mouse-tick infectious cycle. Infect Immun (2011) 0.87
Molecular characterization of the Borrelia burgdorferi in vivo-essential protein PncA. Microbiology (2011) 0.85
Regulation of the virulence determinant OspC by bbd18 on linear plasmid lp17 of Borrelia burgdorferi. J Bacteriol (2011) 0.85
Viral delivery of antioxidant genes as a therapeutic strategy in experimental models of amyotrophic lateral sclerosis. Mol Ther (2013) 0.85
Postoperative hypoxemia in orthopedic patients with obstructive sleep apnea. HSS J (2010) 0.84
Borrelia burgdorferi harbors a transport system essential for purine salvage and mammalian infection. Infect Immun (2012) 0.84
Natural Foxp3(+) regulatory T cells inhibit Th2 polarization but are biased toward suppression of Th17-driven lung inflammation. J Leukoc Biol (2010) 0.84
Relapsing fever spirochaetes produce a serine protease that provides resistance to oxidative stress and killing by neutrophils. Mol Microbiol (2006) 0.83
Reshaping health care delivery for adolescent parents: healthy steps and telemedicine. Telemed J E Health (2003) 0.82
Borrelia burgdorferi resistance to a major skin antimicrobial peptide is independent of outer surface lipoprotein content. Antimicrob Agents Chemother (2009) 0.80
Warm blood cardioplegic arrest induces mitochondrial-mediated cardiomyocyte apoptosis associated with increased urocortin expression in viable cells. J Thorac Cardiovasc Surg (2004) 0.80
Requirements for Borrelia burgdorferi plasmid maintenance. Plasmid (2012) 0.80
lacZ reporter system for use in Borrelia burgdorferi. Appl Environ Microbiol (2010) 0.78
Regulatory protein BBD18 of the lyme disease spirochete: essential role during tick acquisition? MBio (2014) 0.77
The incidence of low back pain in ncaa division iii female field hockey players. Int J Sports Phys Ther (2012) 0.77
Borrelia burgdorferi linear plasmid 28-3 confers a selective advantage in an experimental mouse-tick infection model. Infect Immun (2013) 0.77
The use of subcutaneous glycopyrrolate in the management of sialorrhoea and facilitating the use of non-invasive ventilation in amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2011) 0.76
Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia. Crit Care Med (2016) 0.76
Prevalence of FeLV and antibodies to FIV and FCoV in Falkland Islands cats. Vet Rec (2002) 0.75
Correction: In Vivo Expression Technology Identifies a Novel Virulence Factor Critical for Borrelia burgdorferi Persistence in Mice. PLoS Pathog (2014) 0.75
Comparative utility of centrally versus peripherally transduced venous pressure monitoring in the perioperative period in spine surgery patients. J Clin Anesth (2012) 0.75
The day England's Chief Nurse shadowed me. J Fam Health (2015) 0.75
Concurrent amyotrophic lateral sclerosis and cystic fibrosis supports common pathways of pathogenesis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.75
Welcoming diversity. Community Pract (2006) 0.75
Euthanasia of stranded whales. Vet Rec (2003) 0.75
CPHVA awards Health Visitor of the Year. Community Pract (2012) 0.75
Embryo transfer success in the Falkland Islands. Vet Rec (2003) 0.75